 Lyndsey DuBose
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Stiffness | 18 | 2026 | 487 | 4.020 |
Why?
| | Aging | 13 | 2026 | 1973 | 1.350 |
Why?
| | Testosterone | 5 | 2026 | 416 | 1.240 |
Why?
| | Vascular Diseases | 2 | 2022 | 252 | 1.080 |
Why?
| | Cardiorespiratory Fitness | 4 | 2024 | 74 | 1.070 |
Why?
| | Endothelium, Vascular | 11 | 2026 | 956 | 1.050 |
Why?
| | Carotid Arteries | 8 | 2025 | 208 | 1.000 |
Why?
| | White Matter | 3 | 2024 | 155 | 0.950 |
Why?
| | Fertilization in Vitro | 1 | 2026 | 108 | 0.900 |
Why?
| | Brachial Artery | 7 | 2026 | 208 | 0.830 |
Why?
| | Hypogonadism | 1 | 2024 | 93 | 0.800 |
Why?
| | Vasodilation | 6 | 2026 | 521 | 0.780 |
Why?
| | Menopause | 2 | 2023 | 326 | 0.750 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 290 | 0.740 |
Why?
| | Perimenopause | 1 | 2023 | 69 | 0.720 |
Why?
| | Hypercapnia | 1 | 2022 | 53 | 0.710 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2022 | 203 | 0.690 |
Why?
| | Pulse Wave Analysis | 10 | 2025 | 267 | 0.680 |
Why?
| | Cardiovascular Diseases | 7 | 2026 | 2191 | 0.550 |
Why?
| | Memory, Short-Term | 2 | 2020 | 269 | 0.540 |
Why?
| | Blood Pressure | 10 | 2026 | 1782 | 0.540 |
Why?
| | Blood Flow Velocity | 2 | 2022 | 421 | 0.530 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.520 |
Why?
| | Cognitive Dysfunction | 2 | 2022 | 468 | 0.510 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 188 | 0.480 |
Why?
| | Cognition | 4 | 2021 | 1271 | 0.480 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 286 | 0.450 |
Why?
| | Pre-Eclampsia | 3 | 2023 | 206 | 0.450 |
Why?
| | Executive Function | 1 | 2019 | 470 | 0.430 |
Why?
| | Arterial Pressure | 2 | 2023 | 134 | 0.320 |
Why?
| | Middle Aged | 21 | 2026 | 36302 | 0.320 |
Why?
| | Aged | 17 | 2026 | 26215 | 0.310 |
Why?
| | Oxidative Stress | 4 | 2026 | 1359 | 0.310 |
Why?
| | Aorta | 4 | 2021 | 440 | 0.310 |
Why?
| | Baroreflex | 3 | 2025 | 57 | 0.270 |
Why?
| | Sympathetic Nervous System | 2 | 2019 | 181 | 0.270 |
Why?
| | Humans | 34 | 2026 | 145763 | 0.270 |
Why?
| | Female | 23 | 2026 | 79035 | 0.260 |
Why?
| | Exercise | 4 | 2024 | 2205 | 0.250 |
Why?
| | Adult | 18 | 2026 | 40872 | 0.240 |
Why?
| | Hippocampus | 2 | 2024 | 973 | 0.240 |
Why?
| | Sirtuins | 1 | 2026 | 50 | 0.230 |
Why?
| | Maternal Age | 1 | 2025 | 128 | 0.220 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3915 | 0.210 |
Why?
| | Pregnancy Trimester, Third | 2 | 2023 | 119 | 0.200 |
Why?
| | Male | 21 | 2026 | 73003 | 0.200 |
Why?
| | Atrophy | 1 | 2024 | 199 | 0.200 |
Why?
| | Endothelin-1 | 1 | 2025 | 181 | 0.190 |
Why?
| | Progesterone | 1 | 2024 | 215 | 0.190 |
Why?
| | Estrogens | 2 | 2023 | 367 | 0.190 |
Why?
| | Peroxynitrous Acid | 1 | 2022 | 11 | 0.190 |
Why?
| | Carotid Intima-Media Thickness | 4 | 2025 | 75 | 0.190 |
Why?
| | Estradiol | 2 | 2024 | 515 | 0.190 |
Why?
| | Postpartum Period | 1 | 2025 | 373 | 0.180 |
Why?
| | Aged, 80 and over | 5 | 2024 | 8346 | 0.180 |
Why?
| | Pregnancy | 5 | 2026 | 7215 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 217 | 0.170 |
Why?
| | Young Adult | 8 | 2026 | 14251 | 0.170 |
Why?
| | Vascular Remodeling | 2 | 2023 | 209 | 0.170 |
Why?
| | Nitric Oxide | 2 | 2023 | 892 | 0.170 |
Why?
| | Nitric Oxide Synthase | 1 | 2021 | 234 | 0.170 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2021 | 32 | 0.170 |
Why?
| | Age Factors | 4 | 2025 | 3346 | 0.170 |
Why?
| | Brain | 3 | 2024 | 2969 | 0.160 |
Why?
| | Hyperemia | 1 | 2020 | 49 | 0.160 |
Why?
| | Endothelial Cells | 1 | 2026 | 877 | 0.150 |
Why?
| | Peroneal Nerve | 1 | 2019 | 18 | 0.150 |
Why?
| | Physical Conditioning, Human | 1 | 2020 | 38 | 0.150 |
Why?
| | Receptor, Endothelin B | 1 | 2019 | 43 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2026 | 5922 | 0.150 |
Why?
| | Mitochondria | 1 | 2026 | 992 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 70 | 0.140 |
Why?
| | Association Learning | 1 | 2019 | 70 | 0.140 |
Why?
| | Students | 1 | 2023 | 652 | 0.130 |
Why?
| | Androgens | 1 | 2019 | 181 | 0.130 |
Why?
| | Compliance | 1 | 2017 | 50 | 0.130 |
Why?
| | Trans Fatty Acids | 1 | 2016 | 5 | 0.120 |
Why?
| | Soybean Oil | 1 | 2016 | 15 | 0.120 |
Why?
| | Plant Oils | 1 | 2016 | 33 | 0.120 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 343 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 450 | 0.120 |
Why?
| | Beverages | 1 | 2016 | 68 | 0.120 |
Why?
| | Frontal Lobe | 1 | 2017 | 160 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2022 | 630 | 0.110 |
Why?
| | Risk Factors | 6 | 2024 | 10917 | 0.090 |
Why?
| | Heart Rate | 2 | 2025 | 856 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 1791 | 0.070 |
Why?
| | Mice | 1 | 2026 | 18355 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5428 | 0.070 |
Why?
| | Body Mass Index | 1 | 2017 | 2447 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2025 | 17325 | 0.070 |
Why?
| | Adolescent | 5 | 2026 | 22573 | 0.060 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 56 | 0.050 |
Why?
| | Animals | 1 | 2026 | 38097 | 0.050 |
Why?
| | Carotid Artery, Common | 1 | 2023 | 31 | 0.050 |
Why?
| | Cerebrovascular Disorders | 1 | 2024 | 105 | 0.050 |
Why?
| | Lead | 1 | 2023 | 71 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 266 | 0.050 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2023 | 124 | 0.050 |
Why?
| | Writing | 1 | 2023 | 101 | 0.040 |
Why?
| | omega-N-Methylarginine | 1 | 2021 | 29 | 0.040 |
Why?
| | Memory | 1 | 2024 | 297 | 0.040 |
Why?
| | Plethysmography | 1 | 2022 | 104 | 0.040 |
Why?
| | Elastin | 1 | 2021 | 78 | 0.040 |
Why?
| | Career Choice | 1 | 2023 | 235 | 0.040 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2021 | 69 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2022 | 126 | 0.040 |
Why?
| | Inflammation | 2 | 2023 | 2883 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2024 | 474 | 0.040 |
Why?
| | Arterioles | 1 | 2020 | 52 | 0.040 |
Why?
| | Learning | 1 | 2024 | 444 | 0.040 |
Why?
| | Biomarkers | 2 | 2025 | 4302 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 89 | 0.040 |
Why?
| | Blood Pressure Determination | 1 | 2020 | 145 | 0.040 |
Why?
| | Collagen | 1 | 2021 | 457 | 0.040 |
Why?
| | Antioxidants | 1 | 2022 | 550 | 0.030 |
Why?
| | Organ Size | 1 | 2019 | 461 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2020 | 514 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2021 | 371 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 779 | 0.030 |
Why?
| | Femoral Artery | 1 | 2019 | 190 | 0.030 |
Why?
| | Reaction Time | 1 | 2019 | 434 | 0.030 |
Why?
| | Coconut Oil | 1 | 2016 | 4 | 0.030 |
Why?
| | Iowa | 1 | 2016 | 31 | 0.030 |
Why?
| | Nitrites | 1 | 2016 | 88 | 0.030 |
Why?
| | Nitrates | 1 | 2016 | 96 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3634 | 0.030 |
Why?
| | Postprandial Period | 1 | 2016 | 114 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2139 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1137 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2016 | 610 | 0.030 |
Why?
| | Anxiety | 1 | 2021 | 1122 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 867 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2110 | 0.020 |
Why?
| | Hypertension | 1 | 2020 | 1276 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 8075 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2016 | 1244 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 7133 | 0.010 |
Why?
|
|
DuBose's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|